A carregar...
The potential for BRAF V600 inhibitors in advanced cutaneous melanoma: rationale and latest evidence
Historically, patients with advanced cutaneous melanoma have a poor prognosis and limited treatment options. The discovery of selective v-raf murine sarcoma viral oncogene homolog B1 (BRAF) V600 mutation as an oncogenic mutation in cutaneous melanoma and the importance of the mitogen-activated prote...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3296083/ https://ncbi.nlm.nih.gov/pubmed/22423265 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834011432949 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|